FOUNTAIN INN, S.C., Jan. 5, 2016 (GLOBE NEWSWIRE) -- AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has introduced the new T4C Series HRC4000 medical grade, solid tantalum microchip capacitors. Designed for use in the filtering, hold-up, timing, and pulsing circuits within implantable, non-life-support and non-implantable life support applications, the T4C Microchip Medical Series delivers the smallest medical tantalum capacitors available in the industry (0402 case sizes) with low DC leakage levels (0.01CV or 0.3μA), in addition to change control for consistent supply and high standard reliability better than 0.1% failures per 1,000 hours, which is 10 times better than standard commercial reliability.
T4C Microchip Medical Series capacitors are manufactured and tested using AVX's patented and extremely effective Q-Process technology, which was developed to replace the Weibull Reliability Assessment as the industry standard for tantalum capacitors due to its tendency to burn-in potentially unstable units. In use since 2013, the Q-Process effectively removes components that may experience parametric shifts through customer processing or display instability through life testing, ensures stable and normalized DCL distribution, and provides reliability level verification through life testing to a minimum of 0.1% per 1,000 hours with a 90% confidence level.
"Due to the critical nature of their successful operation, medical implantable, non-life-support and non-implantable life support applications demand electronic components capable of satisfying rigorous performance requirements, including exceptionally high reliability and low DCL," said Brian Brunette, high reliability tantalum applications engineer, AVX. "As the market leader in solid tantalum, medical grade components, our new T4C Microchip Medical Series capacitors deliver unparalleled quality at competitive prices, providing customers with high standard reliability and low DC leakage levels in the smallest medical tantalum case sizes available."
T4C Microchip Medical Series capacitors are currently available in three case sizes (0402, 0603, and 0805), four rated voltages (4V, 6.3V, 10V, and 16V), and with two levels of statistical screening: T4C Standard for standard DCL and ESR limits, and T4C Custom for specific DCL and ESR parameter limits — down to 0.005CV on selected codes. Capacitance values for the series span 0.47μF to 22μF with a ±10% or ±20% capacitance tolerance, and rated operating temperatures range from 55°C to +125°C. Lead-free compatible and RoHS compliant, T4C Series capacitors are available with gold-plated or 100% tin terminations, and packaged in bulk or on 7" or 4.25" reels. Lead time for the series is 10–12 weeks.
For more information about this certification, or to request a specific rating, please contact the factory by calling 207-282-5111.
For more information about AVX's new T4C Series HRC4000 medical grade, solid tantalum microchip capacitors, please visit http://www.avx.com/products/tantalum/high-reliability/medical/t4c-microchip-medical-series/ to access the product datasheet, AVX's High Reliability Tantalum Capacitors catalog, technical and part number information, modeling software, and relevant technical papers, including "Reaching the Highest Reliability for Tantalum Capacitors," which provides in-depth information about AVX's patented Q-Process. For all other inquiries, please visit www.avx.com, call 864-967-2150, or write to One AVX Boulevard, Fountain Inn, S.C. 29644.
About AVX
|
|||||
AVX Corporation is a leading international supplier of electronic passive components and interconnect solutions with 20 manufacturing and warehouse facilities in 11 countries around the world. AVX offers a broad range of devices including capacitors, resistors, filters, timing and circuit protection devices, and connectors. The company is publicly traded on the New York Stock Exchange (NYSE:AVX).
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=38320
CONTACT: Brian Brunette
Applications Engineer, AVX
207-286-2181
[email protected]
Christine Stieglitz
PR Executive, BtB Marketing
919-872-8172
[email protected]


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 



